Global KRAS G12C Inhibitors Market Research Report 2026(Status and Outlook)
KARC G12C inhibitors are targeted therapeutics for G12C mutation, a specific mutation in the KRAS gene. KRAS gene mutations are prevalent in a variety of cancers, particularly in non-small cell lung cancer (NSCLC), where G12C mutations are a common driver. Its mechanism of action is to form covalent bonds with cysteine residues of the KRAS G12C mutant protein, locking KRAS in its inactive conformation and blocking its signaling, thereby inhibiting the proliferation of tumor cells. The development of this class of drugs offers a new therapeutic avenue for cancer patients carrying the KRAS G12C mutation, especially for those who are not sensitive to conventional chemotherapy.
The global KRAS G12C Inhibitors market size was estimated at USD 258.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 47.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global KRAS G12C Inhibitors market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global KRAS G12C Inhibitors market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the KRAS G12C Inhibitors market.
Global KRAS G12C Inhibitors Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Amgen
Innovent Biologics, Inc.
Mirati Therapeutics
Genfleet Therapeutics (Shanghai), Inc.
Market Segmentation (by Type)
Garsorasib
Fulzerasib
Adagrasib
Sotorasib
Market Segmentation (by Application)
Hospital
Clinic
Others
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the KRAS G12C Inhibitors Market
Overview of the regional outlook of the KRAS G12C Inhibitors Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the KRAS G12C Inhibitors Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of KRAS G12C Inhibitors, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global KRAS G12C Inhibitors market size was estimated at USD 258.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 47.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global KRAS G12C Inhibitors market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global KRAS G12C Inhibitors market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the KRAS G12C Inhibitors market.
Global KRAS G12C Inhibitors Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Amgen
Innovent Biologics, Inc.
Mirati Therapeutics
Genfleet Therapeutics (Shanghai), Inc.
Market Segmentation (by Type)
Garsorasib
Fulzerasib
Adagrasib
Sotorasib
Market Segmentation (by Application)
Hospital
Clinic
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the KRAS G12C Inhibitors Market
Overview of the regional outlook of the KRAS G12C Inhibitors Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the KRAS G12C Inhibitors Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of KRAS G12C Inhibitors, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of KRAS G12C Inhibitors
1.2 Key Market Segments
1.2.1 KRAS G12C Inhibitors Segment by Type
1.2.2 KRAS G12C Inhibitors Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 KRAS G12C INHIBITORS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global KRAS G12C Inhibitors Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global KRAS G12C Inhibitors Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 KRAS G12C INHIBITORS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global KRAS G12C Inhibitors Product Life Cycle
3.3 Global KRAS G12C Inhibitors Sales by Manufacturers (2020-2025)
3.4 Global KRAS G12C Inhibitors Revenue Market Share by Manufacturers (2020-2025)
3.5 KRAS G12C Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global KRAS G12C Inhibitors Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 KRAS G12C Inhibitors Market Competitive Situation and Trends
3.8.1 KRAS G12C Inhibitors Market Concentration Rate
3.8.2 Global 5 and 10 Largest KRAS G12C Inhibitors Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 KRAS G12C INHIBITORS INDUSTRY CHAIN ANALYSIS
4.1 KRAS G12C Inhibitors Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF KRAS G12C INHIBITORS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global KRAS G12C Inhibitors Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to KRAS G12C Inhibitors Market
5.7 ESG Ratings of Leading Companies
6 KRAS G12C INHIBITORS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global KRAS G12C Inhibitors Sales Market Share by Type (2020-2025)
6.3 Global KRAS G12C Inhibitors Market Size by Type (2020-2025)
6.4 Global KRAS G12C Inhibitors Price by Type (2020-2025)
7 KRAS G12C INHIBITORS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global KRAS G12C Inhibitors Market Sales by Application (2020-2025)
7.3 Global KRAS G12C Inhibitors Market Size (M USD) by Application (2020-2025)
7.4 Global KRAS G12C Inhibitors Sales Growth Rate by Application (2020-2025)
8 KRAS G12C INHIBITORS MARKET SALES BY REGION
8.1 Global KRAS G12C Inhibitors Sales by Region
8.1.1 Global KRAS G12C Inhibitors Sales by Region
8.1.2 Global KRAS G12C Inhibitors Sales Market Share by Region
8.2 Global KRAS G12C Inhibitors Market Size by Region
8.2.1 Global KRAS G12C Inhibitors Market Size by Region
8.2.2 Global KRAS G12C Inhibitors Market Size by Region
8.3 North America
8.3.1 North America KRAS G12C Inhibitors Sales by Country
8.3.2 North America KRAS G12C Inhibitors Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe KRAS G12C Inhibitors Sales by Country
8.4.2 Europe KRAS G12C Inhibitors Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific KRAS G12C Inhibitors Sales by Region
8.5.2 Asia Pacific KRAS G12C Inhibitors Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America KRAS G12C Inhibitors Sales by Country
8.6.2 South America KRAS G12C Inhibitors Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa KRAS G12C Inhibitors Sales by Region
8.7.2 Middle East and Africa KRAS G12C Inhibitors Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 KRAS G12C INHIBITORS MARKET PRODUCTION BY REGION
9.1 Global Production of KRAS G12C Inhibitors by Region(2020-2025)
9.2 Global KRAS G12C Inhibitors Revenue Market Share by Region (2020-2025)
9.3 Global KRAS G12C Inhibitors Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America KRAS G12C Inhibitors Production
9.4.1 North America KRAS G12C Inhibitors Production Growth Rate (2020-2025)
9.4.2 North America KRAS G12C Inhibitors Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe KRAS G12C Inhibitors Production
9.5.1 Europe KRAS G12C Inhibitors Production Growth Rate (2020-2025)
9.5.2 Europe KRAS G12C Inhibitors Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan KRAS G12C Inhibitors Production (2020-2025)
9.6.1 Japan KRAS G12C Inhibitors Production Growth Rate (2020-2025)
9.6.2 Japan KRAS G12C Inhibitors Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China KRAS G12C Inhibitors Production (2020-2025)
9.7.1 China KRAS G12C Inhibitors Production Growth Rate (2020-2025)
9.7.2 China KRAS G12C Inhibitors Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Amgen
10.1.1 Amgen Basic Information
10.1.2 Amgen KRAS G12C Inhibitors Product Overview
10.1.3 Amgen KRAS G12C Inhibitors Product Market Performance
10.1.4 Amgen Business Overview
10.1.5 Amgen SWOT Analysis
10.1.6 Amgen Recent Developments
10.2 Innovent Biologics, Inc.
10.2.1 Innovent Biologics, Inc. Basic Information
10.2.2 Innovent Biologics, Inc. KRAS G12C Inhibitors Product Overview
10.2.3 Innovent Biologics, Inc. KRAS G12C Inhibitors Product Market Performance
10.2.4 Innovent Biologics, Inc. Business Overview
10.2.5 Innovent Biologics, Inc. SWOT Analysis
10.2.6 Innovent Biologics, Inc. Recent Developments
10.3 Mirati Therapeutics
10.3.1 Mirati Therapeutics Basic Information
10.3.2 Mirati Therapeutics KRAS G12C Inhibitors Product Overview
10.3.3 Mirati Therapeutics KRAS G12C Inhibitors Product Market Performance
10.3.4 Mirati Therapeutics Business Overview
10.3.5 Mirati Therapeutics SWOT Analysis
10.3.6 Mirati Therapeutics Recent Developments
10.4 Genfleet Therapeutics (Shanghai), Inc.
10.4.1 Genfleet Therapeutics (Shanghai), Inc. Basic Information
10.4.2 Genfleet Therapeutics (Shanghai), Inc. KRAS G12C Inhibitors Product Overview
10.4.3 Genfleet Therapeutics (Shanghai), Inc. KRAS G12C Inhibitors Product Market Performance
10.4.4 Genfleet Therapeutics (Shanghai), Inc. Business Overview
10.4.5 Genfleet Therapeutics (Shanghai), Inc. Recent Developments
11 KRAS G12C INHIBITORS MARKET FORECAST BY REGION
11.1 Global KRAS G12C Inhibitors Market Size Forecast
11.2 Global KRAS G12C Inhibitors Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe KRAS G12C Inhibitors Market Size Forecast by Country
11.2.3 Asia Pacific KRAS G12C Inhibitors Market Size Forecast by Region
11.2.4 South America KRAS G12C Inhibitors Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of KRAS G12C Inhibitors by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global KRAS G12C Inhibitors Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of KRAS G12C Inhibitors by Type (2026-2035)
12.1.2 Global KRAS G12C Inhibitors Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of KRAS G12C Inhibitors by Type (2026-2035)
12.2 Global KRAS G12C Inhibitors Market Forecast by Application (2026-2035)
12.2.1 Global KRAS G12C Inhibitors Sales (K MT) Forecast by Application
12.2.2 Global KRAS G12C Inhibitors Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of KRAS G12C Inhibitors
1.2 Key Market Segments
1.2.1 KRAS G12C Inhibitors Segment by Type
1.2.2 KRAS G12C Inhibitors Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 KRAS G12C INHIBITORS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global KRAS G12C Inhibitors Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global KRAS G12C Inhibitors Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 KRAS G12C INHIBITORS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global KRAS G12C Inhibitors Product Life Cycle
3.3 Global KRAS G12C Inhibitors Sales by Manufacturers (2020-2025)
3.4 Global KRAS G12C Inhibitors Revenue Market Share by Manufacturers (2020-2025)
3.5 KRAS G12C Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global KRAS G12C Inhibitors Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 KRAS G12C Inhibitors Market Competitive Situation and Trends
3.8.1 KRAS G12C Inhibitors Market Concentration Rate
3.8.2 Global 5 and 10 Largest KRAS G12C Inhibitors Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 KRAS G12C INHIBITORS INDUSTRY CHAIN ANALYSIS
4.1 KRAS G12C Inhibitors Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF KRAS G12C INHIBITORS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global KRAS G12C Inhibitors Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to KRAS G12C Inhibitors Market
5.7 ESG Ratings of Leading Companies
6 KRAS G12C INHIBITORS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global KRAS G12C Inhibitors Sales Market Share by Type (2020-2025)
6.3 Global KRAS G12C Inhibitors Market Size by Type (2020-2025)
6.4 Global KRAS G12C Inhibitors Price by Type (2020-2025)
7 KRAS G12C INHIBITORS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global KRAS G12C Inhibitors Market Sales by Application (2020-2025)
7.3 Global KRAS G12C Inhibitors Market Size (M USD) by Application (2020-2025)
7.4 Global KRAS G12C Inhibitors Sales Growth Rate by Application (2020-2025)
8 KRAS G12C INHIBITORS MARKET SALES BY REGION
8.1 Global KRAS G12C Inhibitors Sales by Region
8.1.1 Global KRAS G12C Inhibitors Sales by Region
8.1.2 Global KRAS G12C Inhibitors Sales Market Share by Region
8.2 Global KRAS G12C Inhibitors Market Size by Region
8.2.1 Global KRAS G12C Inhibitors Market Size by Region
8.2.2 Global KRAS G12C Inhibitors Market Size by Region
8.3 North America
8.3.1 North America KRAS G12C Inhibitors Sales by Country
8.3.2 North America KRAS G12C Inhibitors Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe KRAS G12C Inhibitors Sales by Country
8.4.2 Europe KRAS G12C Inhibitors Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific KRAS G12C Inhibitors Sales by Region
8.5.2 Asia Pacific KRAS G12C Inhibitors Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America KRAS G12C Inhibitors Sales by Country
8.6.2 South America KRAS G12C Inhibitors Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa KRAS G12C Inhibitors Sales by Region
8.7.2 Middle East and Africa KRAS G12C Inhibitors Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 KRAS G12C INHIBITORS MARKET PRODUCTION BY REGION
9.1 Global Production of KRAS G12C Inhibitors by Region(2020-2025)
9.2 Global KRAS G12C Inhibitors Revenue Market Share by Region (2020-2025)
9.3 Global KRAS G12C Inhibitors Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America KRAS G12C Inhibitors Production
9.4.1 North America KRAS G12C Inhibitors Production Growth Rate (2020-2025)
9.4.2 North America KRAS G12C Inhibitors Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe KRAS G12C Inhibitors Production
9.5.1 Europe KRAS G12C Inhibitors Production Growth Rate (2020-2025)
9.5.2 Europe KRAS G12C Inhibitors Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan KRAS G12C Inhibitors Production (2020-2025)
9.6.1 Japan KRAS G12C Inhibitors Production Growth Rate (2020-2025)
9.6.2 Japan KRAS G12C Inhibitors Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China KRAS G12C Inhibitors Production (2020-2025)
9.7.1 China KRAS G12C Inhibitors Production Growth Rate (2020-2025)
9.7.2 China KRAS G12C Inhibitors Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Amgen
10.1.1 Amgen Basic Information
10.1.2 Amgen KRAS G12C Inhibitors Product Overview
10.1.3 Amgen KRAS G12C Inhibitors Product Market Performance
10.1.4 Amgen Business Overview
10.1.5 Amgen SWOT Analysis
10.1.6 Amgen Recent Developments
10.2 Innovent Biologics, Inc.
10.2.1 Innovent Biologics, Inc. Basic Information
10.2.2 Innovent Biologics, Inc. KRAS G12C Inhibitors Product Overview
10.2.3 Innovent Biologics, Inc. KRAS G12C Inhibitors Product Market Performance
10.2.4 Innovent Biologics, Inc. Business Overview
10.2.5 Innovent Biologics, Inc. SWOT Analysis
10.2.6 Innovent Biologics, Inc. Recent Developments
10.3 Mirati Therapeutics
10.3.1 Mirati Therapeutics Basic Information
10.3.2 Mirati Therapeutics KRAS G12C Inhibitors Product Overview
10.3.3 Mirati Therapeutics KRAS G12C Inhibitors Product Market Performance
10.3.4 Mirati Therapeutics Business Overview
10.3.5 Mirati Therapeutics SWOT Analysis
10.3.6 Mirati Therapeutics Recent Developments
10.4 Genfleet Therapeutics (Shanghai), Inc.
10.4.1 Genfleet Therapeutics (Shanghai), Inc. Basic Information
10.4.2 Genfleet Therapeutics (Shanghai), Inc. KRAS G12C Inhibitors Product Overview
10.4.3 Genfleet Therapeutics (Shanghai), Inc. KRAS G12C Inhibitors Product Market Performance
10.4.4 Genfleet Therapeutics (Shanghai), Inc. Business Overview
10.4.5 Genfleet Therapeutics (Shanghai), Inc. Recent Developments
11 KRAS G12C INHIBITORS MARKET FORECAST BY REGION
11.1 Global KRAS G12C Inhibitors Market Size Forecast
11.2 Global KRAS G12C Inhibitors Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe KRAS G12C Inhibitors Market Size Forecast by Country
11.2.3 Asia Pacific KRAS G12C Inhibitors Market Size Forecast by Region
11.2.4 South America KRAS G12C Inhibitors Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of KRAS G12C Inhibitors by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global KRAS G12C Inhibitors Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of KRAS G12C Inhibitors by Type (2026-2035)
12.1.2 Global KRAS G12C Inhibitors Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of KRAS G12C Inhibitors by Type (2026-2035)
12.2 Global KRAS G12C Inhibitors Market Forecast by Application (2026-2035)
12.2.1 Global KRAS G12C Inhibitors Sales (K MT) Forecast by Application
12.2.2 Global KRAS G12C Inhibitors Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global KRAS G12C Inhibitors Market Size by Type (M USD)
Table 4. Global KRAS G12C Inhibitors Market Size by Application
Table 5. KRAS G12C Inhibitors Market Size Comparison by Region (M USD)
Table 6. Global KRAS G12C Inhibitors Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global KRAS G12C Inhibitors Sales Market Share by Manufacturers (2020-2025)
Table 8. Global KRAS G12C Inhibitors Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global KRAS G12C Inhibitors Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in KRAS G12C Inhibitors as of 2025)
Table 11. Global Market KRAS G12C Inhibitors Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global KRAS G12C Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. KRAS G12C Inhibitors Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global KRAS G12C Inhibitors Sales by Type (K MT)
Table 27. Global KRAS G12C Inhibitors Market Size by Type (M USD)
Table 28. Global KRAS G12C Inhibitors Sales (K MT) by Type (2020-2025)
Table 29. Global KRAS G12C Inhibitors Sales Market Share by Type (2020-2025)
Table 30. Global KRAS G12C Inhibitors Market Size (M USD) by Type (2020-2025)
Table 31. Global KRAS G12C Inhibitors Market Share by Type (2020-2025)
Table 32. Global KRAS G12C Inhibitors Price (USD/KG) by Type (2020-2025)
Table 33. Global KRAS G12C Inhibitors Sales (K MT) by Application
Table 34. Global KRAS G12C Inhibitors Market Size by Application
Table 35. Global KRAS G12C Inhibitors Sales by Application (2020-2025) & (K MT)
Table 36. Global KRAS G12C Inhibitors Sales Market Share by Application (2020-2025)
Table 37. Global KRAS G12C Inhibitors Market Size by Application (2020-2025) & (M USD)
Table 38. Global KRAS G12C Inhibitors Market Share by Application (2020-2025)
Table 39. Global KRAS G12C Inhibitors Sales Growth Rate by Application (2020-2025)
Table 40. Global KRAS G12C Inhibitors Sales by Region (2020-2025) & (K MT)
Table 41. Global KRAS G12C Inhibitors Sales Market Share by Region (2020-2025)
Table 42. Global KRAS G12C Inhibitors Market Size by Region (2020-2025) & (M USD)
Table 43. Global KRAS G12C Inhibitors Market Size by Region (2020-2025)
Table 44. North America KRAS G12C Inhibitors Sales by Country (2020-2025) & (K MT)
Table 45. North America KRAS G12C Inhibitors Market Size by Country (2020-2025) & (M USD)
Table 46. Europe KRAS G12C Inhibitors Sales by Country (2020-2025) & (K MT)
Table 47. Europe KRAS G12C Inhibitors Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific KRAS G12C Inhibitors Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific KRAS G12C Inhibitors Market Size by Region (2020-2025) & (M USD)
Table 50. South America KRAS G12C Inhibitors Sales by Country (2020-2025) & (K MT)
Table 51. South America KRAS G12C Inhibitors Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa KRAS G12C Inhibitors Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa KRAS G12C Inhibitors Market Size by Region (2020-2025) & (M USD)
Table 54. Global KRAS G12C Inhibitors Production (K MT) by Region(2020-2025)
Table 55. Global KRAS G12C Inhibitors Revenue (US$ Million) by Region (2020-2025)
Table 56. Global KRAS G12C Inhibitors Revenue Market Share by Region (2020-2025)
Table 57. Global KRAS G12C Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America KRAS G12C Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe KRAS G12C Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan KRAS G12C Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China KRAS G12C Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Amgen Basic Information
Table 63. Amgen KRAS G12C Inhibitors Product Overview
Table 64. Amgen KRAS G12C Inhibitors Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Amgen Business Overview
Table 66. Amgen SWOT Analysis
Table 67. Amgen Recent Developments
Table 68. Innovent Biologics, Inc. Basic Information
Table 69. Innovent Biologics, Inc. KRAS G12C Inhibitors Product Overview
Table 70. Innovent Biologics, Inc. KRAS G12C Inhibitors Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Innovent Biologics, Inc. Business Overview
Table 72. Innovent Biologics, Inc. SWOT Analysis
Table 73. Innovent Biologics, Inc. Recent Developments
Table 74. Mirati Therapeutics Basic Information
Table 75. Mirati Therapeutics KRAS G12C Inhibitors Product Overview
Table 76. Mirati Therapeutics KRAS G12C Inhibitors Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Mirati Therapeutics Business Overview
Table 78. Mirati Therapeutics SWOT Analysis
Table 79. Mirati Therapeutics Recent Developments
Table 80. Genfleet Therapeutics (Shanghai), Inc. Basic Information
Table 81. Genfleet Therapeutics (Shanghai), Inc. KRAS G12C Inhibitors Product Overview
Table 82. Genfleet Therapeutics (Shanghai), Inc. KRAS G12C Inhibitors Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Genfleet Therapeutics (Shanghai), Inc. Business Overview
Table 84. Genfleet Therapeutics (Shanghai), Inc. Recent Developments
Table 85. Global KRAS G12C Inhibitors Sales Forecast by Region (2026-2035) & (K MT)
Table 86. Global KRAS G12C Inhibitors Market Size Forecast by Region (2026-2035) & (M USD)
Table 87. North America KRAS G12C Inhibitors Sales Forecast by Country (2026-2035) & (K MT)
Table 88. North America KRAS G12C Inhibitors Market Size Forecast by Country (2026-2035) & (M USD)
Table 89. Europe KRAS G12C Inhibitors Sales Forecast by Country (2026-2035) & (K MT)
Table 90. Europe KRAS G12C Inhibitors Market Size Forecast by Country (2026-2035) & (M USD)
Table 91. Asia Pacific KRAS G12C Inhibitors Sales Forecast by Region (2026-2035) & (K MT)
Table 92. Asia Pacific KRAS G12C Inhibitors Market Size Forecast by Region (2026-2035) & (M USD)
Table 93. South America KRAS G12C Inhibitors Sales Forecast by Country (2026-2035) & (K MT)
Table 94. South America KRAS G12C Inhibitors Market Size Forecast by Country (2026-2035) & (M USD)
Table 95. Middle East and Africa KRAS G12C Inhibitors Sales Forecast by Country (2026-2035) & (Units)
Table 96. Middle East and Africa KRAS G12C Inhibitors Market Size Forecast by Country (2026-2035) & (M USD)
Table 97. Global KRAS G12C Inhibitors Sales Forecast by Type (2026-2035) & (K MT)
Table 98. Global KRAS G12C Inhibitors Market Size Forecast by Type (2026-2035) & (M USD)
Table 99. Global KRAS G12C Inhibitors Price Forecast by Type (2026-2035) & (USD/KG)
Table 100. Global KRAS G12C Inhibitors Sales (K MT) Forecast by Application (2026-2035)
Table 101. Global KRAS G12C Inhibitors Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global KRAS G12C Inhibitors Market Size by Type (M USD)
Table 4. Global KRAS G12C Inhibitors Market Size by Application
Table 5. KRAS G12C Inhibitors Market Size Comparison by Region (M USD)
Table 6. Global KRAS G12C Inhibitors Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global KRAS G12C Inhibitors Sales Market Share by Manufacturers (2020-2025)
Table 8. Global KRAS G12C Inhibitors Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global KRAS G12C Inhibitors Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in KRAS G12C Inhibitors as of 2025)
Table 11. Global Market KRAS G12C Inhibitors Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global KRAS G12C Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. KRAS G12C Inhibitors Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global KRAS G12C Inhibitors Sales by Type (K MT)
Table 27. Global KRAS G12C Inhibitors Market Size by Type (M USD)
Table 28. Global KRAS G12C Inhibitors Sales (K MT) by Type (2020-2025)
Table 29. Global KRAS G12C Inhibitors Sales Market Share by Type (2020-2025)
Table 30. Global KRAS G12C Inhibitors Market Size (M USD) by Type (2020-2025)
Table 31. Global KRAS G12C Inhibitors Market Share by Type (2020-2025)
Table 32. Global KRAS G12C Inhibitors Price (USD/KG) by Type (2020-2025)
Table 33. Global KRAS G12C Inhibitors Sales (K MT) by Application
Table 34. Global KRAS G12C Inhibitors Market Size by Application
Table 35. Global KRAS G12C Inhibitors Sales by Application (2020-2025) & (K MT)
Table 36. Global KRAS G12C Inhibitors Sales Market Share by Application (2020-2025)
Table 37. Global KRAS G12C Inhibitors Market Size by Application (2020-2025) & (M USD)
Table 38. Global KRAS G12C Inhibitors Market Share by Application (2020-2025)
Table 39. Global KRAS G12C Inhibitors Sales Growth Rate by Application (2020-2025)
Table 40. Global KRAS G12C Inhibitors Sales by Region (2020-2025) & (K MT)
Table 41. Global KRAS G12C Inhibitors Sales Market Share by Region (2020-2025)
Table 42. Global KRAS G12C Inhibitors Market Size by Region (2020-2025) & (M USD)
Table 43. Global KRAS G12C Inhibitors Market Size by Region (2020-2025)
Table 44. North America KRAS G12C Inhibitors Sales by Country (2020-2025) & (K MT)
Table 45. North America KRAS G12C Inhibitors Market Size by Country (2020-2025) & (M USD)
Table 46. Europe KRAS G12C Inhibitors Sales by Country (2020-2025) & (K MT)
Table 47. Europe KRAS G12C Inhibitors Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific KRAS G12C Inhibitors Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific KRAS G12C Inhibitors Market Size by Region (2020-2025) & (M USD)
Table 50. South America KRAS G12C Inhibitors Sales by Country (2020-2025) & (K MT)
Table 51. South America KRAS G12C Inhibitors Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa KRAS G12C Inhibitors Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa KRAS G12C Inhibitors Market Size by Region (2020-2025) & (M USD)
Table 54. Global KRAS G12C Inhibitors Production (K MT) by Region(2020-2025)
Table 55. Global KRAS G12C Inhibitors Revenue (US$ Million) by Region (2020-2025)
Table 56. Global KRAS G12C Inhibitors Revenue Market Share by Region (2020-2025)
Table 57. Global KRAS G12C Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America KRAS G12C Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe KRAS G12C Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan KRAS G12C Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China KRAS G12C Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Amgen Basic Information
Table 63. Amgen KRAS G12C Inhibitors Product Overview
Table 64. Amgen KRAS G12C Inhibitors Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Amgen Business Overview
Table 66. Amgen SWOT Analysis
Table 67. Amgen Recent Developments
Table 68. Innovent Biologics, Inc. Basic Information
Table 69. Innovent Biologics, Inc. KRAS G12C Inhibitors Product Overview
Table 70. Innovent Biologics, Inc. KRAS G12C Inhibitors Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Innovent Biologics, Inc. Business Overview
Table 72. Innovent Biologics, Inc. SWOT Analysis
Table 73. Innovent Biologics, Inc. Recent Developments
Table 74. Mirati Therapeutics Basic Information
Table 75. Mirati Therapeutics KRAS G12C Inhibitors Product Overview
Table 76. Mirati Therapeutics KRAS G12C Inhibitors Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Mirati Therapeutics Business Overview
Table 78. Mirati Therapeutics SWOT Analysis
Table 79. Mirati Therapeutics Recent Developments
Table 80. Genfleet Therapeutics (Shanghai), Inc. Basic Information
Table 81. Genfleet Therapeutics (Shanghai), Inc. KRAS G12C Inhibitors Product Overview
Table 82. Genfleet Therapeutics (Shanghai), Inc. KRAS G12C Inhibitors Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Genfleet Therapeutics (Shanghai), Inc. Business Overview
Table 84. Genfleet Therapeutics (Shanghai), Inc. Recent Developments
Table 85. Global KRAS G12C Inhibitors Sales Forecast by Region (2026-2035) & (K MT)
Table 86. Global KRAS G12C Inhibitors Market Size Forecast by Region (2026-2035) & (M USD)
Table 87. North America KRAS G12C Inhibitors Sales Forecast by Country (2026-2035) & (K MT)
Table 88. North America KRAS G12C Inhibitors Market Size Forecast by Country (2026-2035) & (M USD)
Table 89. Europe KRAS G12C Inhibitors Sales Forecast by Country (2026-2035) & (K MT)
Table 90. Europe KRAS G12C Inhibitors Market Size Forecast by Country (2026-2035) & (M USD)
Table 91. Asia Pacific KRAS G12C Inhibitors Sales Forecast by Region (2026-2035) & (K MT)
Table 92. Asia Pacific KRAS G12C Inhibitors Market Size Forecast by Region (2026-2035) & (M USD)
Table 93. South America KRAS G12C Inhibitors Sales Forecast by Country (2026-2035) & (K MT)
Table 94. South America KRAS G12C Inhibitors Market Size Forecast by Country (2026-2035) & (M USD)
Table 95. Middle East and Africa KRAS G12C Inhibitors Sales Forecast by Country (2026-2035) & (Units)
Table 96. Middle East and Africa KRAS G12C Inhibitors Market Size Forecast by Country (2026-2035) & (M USD)
Table 97. Global KRAS G12C Inhibitors Sales Forecast by Type (2026-2035) & (K MT)
Table 98. Global KRAS G12C Inhibitors Market Size Forecast by Type (2026-2035) & (M USD)
Table 99. Global KRAS G12C Inhibitors Price Forecast by Type (2026-2035) & (USD/KG)
Table 100. Global KRAS G12C Inhibitors Sales (K MT) Forecast by Application (2026-2035)
Table 101. Global KRAS G12C Inhibitors Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of KRAS G12C Inhibitors
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global KRAS G12C Inhibitors Market Size (M USD), 2025-2035
Figure 5. Global KRAS G12C Inhibitors Market Size (M USD) (2020-2035)
Figure 6. Global KRAS G12C Inhibitors Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. KRAS G12C Inhibitors Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global KRAS G12C Inhibitors Product Life Cycle
Figure 13. KRAS G12C Inhibitors Sales Share by Manufacturers in 2025
Figure 14. Global KRAS G12C Inhibitors Revenue Share by Manufacturers in 2025
Figure 15. KRAS G12C Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market KRAS G12C Inhibitors Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by KRAS G12C Inhibitors Revenue in 2025
Figure 18. Industry Chain Map of KRAS G12C Inhibitors
Figure 19. Global KRAS G12C Inhibitors Market PEST Analysis
Figure 20. Global KRAS G12C Inhibitors Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global KRAS G12C Inhibitors Market Share by Type
Figure 27. Sales Market Share of KRAS G12C Inhibitors by Type (2020-2025)
Figure 28. Sales Market Share of KRAS G12C Inhibitors by Type in 2025
Figure 29. Market Share of KRAS G12C Inhibitors by Type (2020-2025)
Figure 30. Market Share of KRAS G12C Inhibitors by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global KRAS G12C Inhibitors Market Share by Application
Figure 33. Global KRAS G12C Inhibitors Sales Market Share by Application (2020-2025)
Figure 34. Global KRAS G12C Inhibitors Sales Market Share by Application in 2025
Figure 35. Global KRAS G12C Inhibitors Market Share by Application (2020-2025)
Figure 36. Global KRAS G12C Inhibitors Market Share by Application in 2025
Figure 37. Global KRAS G12C Inhibitors Sales Growth Rate by Application (2020-2025)
Figure 38. Global KRAS G12C Inhibitors Sales Market Share by Region (2020-2025)
Figure 39. Global KRAS G12C Inhibitors Market Size by Region (2020-2025)
Figure 40. North America KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America KRAS G12C Inhibitors Sales Market Share by Country in 2024
Figure 43. North America KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America KRAS G12C Inhibitors Market Size by Country in 2024
Figure 45. U.S. KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada KRAS G12C Inhibitors Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada KRAS G12C Inhibitors Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico KRAS G12C Inhibitors Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico KRAS G12C Inhibitors Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe KRAS G12C Inhibitors Sales Market Share by Country in 2024
Figure 53. Europe KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe KRAS G12C Inhibitors Market Size by Country in 2024
Figure 55. Germany KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific KRAS G12C Inhibitors Sales and Growth Rate (K MT)
Figure 66. Asia Pacific KRAS G12C Inhibitors Sales Market Share by Region in 2024
Figure 67. Asia Pacific KRAS G12C Inhibitors Market Size by Region in 2024
Figure 68. China KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America KRAS G12C Inhibitors Sales and Growth Rate (K MT)
Figure 79. South America KRAS G12C Inhibitors Sales Market Share by Country in 2024
Figure 80. South America KRAS G12C Inhibitors Market Size and Growth Rate (M USD)
Figure 81. South America KRAS G12C Inhibitors Market Size by Country in 2024
Figure 82. Brazil KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa KRAS G12C Inhibitors Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa KRAS G12C Inhibitors Sales Market Share by Region in 2024
Figure 90. Middle East and Africa KRAS G12C Inhibitors Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa KRAS G12C Inhibitors Market Size by Region in 2024
Figure 92. Saudi Arabia KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global KRAS G12C Inhibitors Production Market Share by Region (2020-2025)
Figure 103. North America KRAS G12C Inhibitors Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe KRAS G12C Inhibitors Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan KRAS G12C Inhibitors Production (K MT) Growth Rate (2020-2025)
Figure 106. China KRAS G12C Inhibitors Production (K MT) Growth Rate (2020-2025)
Figure 107. Global KRAS G12C Inhibitors Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global KRAS G12C Inhibitors Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global KRAS G12C Inhibitors Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global KRAS G12C Inhibitors Market Share Forecast by Type (2026-2035)
Figure 111. Global KRAS G12C Inhibitors Sales Forecast by Application (2026-2035)
Figure 112. Global KRAS G12C Inhibitors Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of KRAS G12C Inhibitors
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global KRAS G12C Inhibitors Market Size (M USD), 2025-2035
Figure 5. Global KRAS G12C Inhibitors Market Size (M USD) (2020-2035)
Figure 6. Global KRAS G12C Inhibitors Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. KRAS G12C Inhibitors Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global KRAS G12C Inhibitors Product Life Cycle
Figure 13. KRAS G12C Inhibitors Sales Share by Manufacturers in 2025
Figure 14. Global KRAS G12C Inhibitors Revenue Share by Manufacturers in 2025
Figure 15. KRAS G12C Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market KRAS G12C Inhibitors Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by KRAS G12C Inhibitors Revenue in 2025
Figure 18. Industry Chain Map of KRAS G12C Inhibitors
Figure 19. Global KRAS G12C Inhibitors Market PEST Analysis
Figure 20. Global KRAS G12C Inhibitors Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global KRAS G12C Inhibitors Market Share by Type
Figure 27. Sales Market Share of KRAS G12C Inhibitors by Type (2020-2025)
Figure 28. Sales Market Share of KRAS G12C Inhibitors by Type in 2025
Figure 29. Market Share of KRAS G12C Inhibitors by Type (2020-2025)
Figure 30. Market Share of KRAS G12C Inhibitors by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global KRAS G12C Inhibitors Market Share by Application
Figure 33. Global KRAS G12C Inhibitors Sales Market Share by Application (2020-2025)
Figure 34. Global KRAS G12C Inhibitors Sales Market Share by Application in 2025
Figure 35. Global KRAS G12C Inhibitors Market Share by Application (2020-2025)
Figure 36. Global KRAS G12C Inhibitors Market Share by Application in 2025
Figure 37. Global KRAS G12C Inhibitors Sales Growth Rate by Application (2020-2025)
Figure 38. Global KRAS G12C Inhibitors Sales Market Share by Region (2020-2025)
Figure 39. Global KRAS G12C Inhibitors Market Size by Region (2020-2025)
Figure 40. North America KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America KRAS G12C Inhibitors Sales Market Share by Country in 2024
Figure 43. North America KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America KRAS G12C Inhibitors Market Size by Country in 2024
Figure 45. U.S. KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada KRAS G12C Inhibitors Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada KRAS G12C Inhibitors Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico KRAS G12C Inhibitors Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico KRAS G12C Inhibitors Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe KRAS G12C Inhibitors Sales Market Share by Country in 2024
Figure 53. Europe KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe KRAS G12C Inhibitors Market Size by Country in 2024
Figure 55. Germany KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific KRAS G12C Inhibitors Sales and Growth Rate (K MT)
Figure 66. Asia Pacific KRAS G12C Inhibitors Sales Market Share by Region in 2024
Figure 67. Asia Pacific KRAS G12C Inhibitors Market Size by Region in 2024
Figure 68. China KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America KRAS G12C Inhibitors Sales and Growth Rate (K MT)
Figure 79. South America KRAS G12C Inhibitors Sales Market Share by Country in 2024
Figure 80. South America KRAS G12C Inhibitors Market Size and Growth Rate (M USD)
Figure 81. South America KRAS G12C Inhibitors Market Size by Country in 2024
Figure 82. Brazil KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa KRAS G12C Inhibitors Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa KRAS G12C Inhibitors Sales Market Share by Region in 2024
Figure 90. Middle East and Africa KRAS G12C Inhibitors Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa KRAS G12C Inhibitors Market Size by Region in 2024
Figure 92. Saudi Arabia KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa KRAS G12C Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa KRAS G12C Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global KRAS G12C Inhibitors Production Market Share by Region (2020-2025)
Figure 103. North America KRAS G12C Inhibitors Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe KRAS G12C Inhibitors Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan KRAS G12C Inhibitors Production (K MT) Growth Rate (2020-2025)
Figure 106. China KRAS G12C Inhibitors Production (K MT) Growth Rate (2020-2025)
Figure 107. Global KRAS G12C Inhibitors Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global KRAS G12C Inhibitors Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global KRAS G12C Inhibitors Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global KRAS G12C Inhibitors Market Share Forecast by Type (2026-2035)
Figure 111. Global KRAS G12C Inhibitors Sales Forecast by Application (2026-2035)
Figure 112. Global KRAS G12C Inhibitors Market Share Forecast by Application (2026-2035)
